U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H12I3N2O2.Na
Molecular Weight 619.9391
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of IPODATE SODIUM

SMILES

[Na+].CN(C)C=NC1=C(I)C(CCC([O-])=O)=C(I)C=C1I

InChI

InChIKey=ZFHZUGUCWJVEQC-UHFFFAOYSA-M
InChI=1S/C12H13I3N2O2.Na/c1-17(2)6-16-12-9(14)5-8(13)7(11(12)15)3-4-10(18)19;/h5-6H,3-4H2,1-2H3,(H,18,19);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula C12H12I3N2O2
Molecular Weight 596.9493
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Iopanoic acid and ipodate salts have been used for oral cholangiography to visualize the biliary ducts. Ipodate salts have been used for the long-term treatment of Graves' disease and in hyperthyroidism. Ipodate reduced levels of T3 and T4 in the patients. Ipodate also inhibits the conversion of T4 to T3. It is not considered a first-line approach. Ipodate sodium lacks FDA approval for these uses. During investigation of mechanism of action was discovered, that binding of sodium ipodate with nuclear T3 receptors was not a prominent mechanism via which the drug attenuates T3 effects in vivo. Sodium ipodate could enhance T3 effects at the cellular level and that enhancement could not be reflected by routinely monitored serum TSH.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
ORAGRAFIN SODIUM

Approved Use

Unknown

Launch Date

-2.37340803E11
Primary
ORAGRAFIN SODIUM

Approved Use

Unknown

Launch Date

-2.37340803E11
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
250 μM
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
IPODIC ACID blood
Canis lupus
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1600 μM × h
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
IPODIC ACID blood
Canis lupus
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
12 h
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
IPODIC ACID blood
Canis lupus
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
PubMed

PubMed

TitleDatePubMed
A study of cardiac effects of thyroid hormones: evidence for amelioration of the effects of thyroxine by sodium ipodate.
1984 Jun
The use of oral radiographic contrast agents in the management of hyperthyroidism.
2001 Jun
Use of oral cholecystography agents in the treatment of hyperthyroidism of subacute thyroiditis.
2003 Mar
Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases.
2007 Jun
Patents

Patents

Sample Use Guides

hyperthyroidism: Oragrafin; 0.5 g, orally daily or every other day) for 15-60 day Graves' hyperthyroidism: 500 mg, orally, daily for 23-31 weeks
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:05:39 UTC 2023
Edited
by admin
on Fri Dec 15 15:05:39 UTC 2023
Record UNII
F316LLW9WW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IPODATE SODIUM
ORANGE BOOK   USAN   USP   VANDF  
USAN  
Official Name English
NSC-106962
Code English
Sodium 3-[[(dimethylamino)methylene]amino]-2,4,6-triiodohydrocinnamate
Systematic Name English
SODIUM IOPODATE
INN   JAN   MART.  
INN  
Official Name English
SODIUM IOPODATE [MART.]
Common Name English
IPODATE SODIUM [VANDF]
Common Name English
IOPODATE SODIUM
WHO-DD  
Common Name English
IPODATE SODIUM SALT [MI]
Common Name English
IPODATE SODIUM [ORANGE BOOK]
Common Name English
BILIVIST
Brand Name English
SODIUM IPODATE
Common Name English
sodium iopodate [INN]
Common Name English
Iopodate sodium [WHO-DD]
Common Name English
ORAGRAFIN SODIUM
Brand Name English
SODIUM IOPODATE [JAN]
Common Name English
IPODATE SODIUM [USAN]
Common Name English
IPODATE SODIUM [USP IMPURITY]
Common Name English
IPODATE SODIUM SALT
MI  
Common Name English
BENZENEPROPANOIC ACID, 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODO-, SODIUM SALT
Common Name English
Classification Tree Code System Code
WHO-VATC QV08AC08
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
WHO-ATC V08AC08
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
NCI_THESAURUS C1937
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
Code System Code Type Description
SMS_ID
100000077382
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
CAS
1221-56-3
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
ChEMBL
CHEMBL1201243
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
FDA UNII
F316LLW9WW
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
INN
1033
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
EPA CompTox
DTXSID9048271
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
NCI_THESAURUS
C65954
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
ECHA (EC/EINECS)
214-945-3
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
DRUG BANK
DBSALT001318
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
EVMPD
SUB14256MIG
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
RXCUI
9887
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY RxNorm
PUBCHEM
23671932
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
MERCK INDEX
m6385
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY Merck Index
NSC
106962
Created by admin on Fri Dec 15 15:05:39 UTC 2023 , Edited by admin on Fri Dec 15 15:05:39 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY